Ltr Pharma (LTP) Short Interest
Ltr Pharma (ASX:LTP) had 0.09% of shares reported as short positions as of 24 Aug 2026, representing 172,334 shares. Ltr Pharma operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Ltr Pharma
LTR Pharma is an Australian drug development company focused on men's health, specifically commercializing a rapid-onset, on-demand therapeutic nasal spray for erectile dysfunction. Their lead product, SPONTAN®, utilizes intranasal delivery technology of a PDE5 inhibitor, aiming for faster action and improved spontaneity compared to existing ED therapies.
Short position
Ltr Pharma (ASX:LTP) has 0.09% of its shares on issue reported as short positions as of 24 Aug 2026, or about 172,334 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.17 percentage points. Its highest recorded short interest was 0.39% in November 2025. LTP is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4LTP intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Ltr Pharma
Latest LTP news
All news- FY26 Results Announcement
asx
- Appendix 4G and Corporate Governance Statement
asx
- Appendix 4E and Annual Report to Shareholders
asx
- LTR Pharma (ASX:LTP) Rises As US Commercial Pathway Expands - Kalkine
googlenews
- LTR Pharma (ASX:LTP) posts 93% response in 147-patient SPONTAN study as US launch nears - Stocks Down Under
googlenews
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss LTP
Start a research thread or post the first pulse update